Veri Medtech Holdings, Inc. VRHI
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -33.66% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -33.66% | -- | -- | -- |
| Cost of Revenue | -- | -37.29% | -- | -- | -- |
| Gross Profit | -- | -32.40% | -- | -- | -- |
| SG&A Expenses | -- | -16.28% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -21.48% | -- | -- | -- |
| Operating Income | -- | -272.04% | -- | -- | -- |
| Income Before Tax | -- | -230.35% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -235.77% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -235.77% | -- | -- | -- |
| EBIT | -- | -272.04% | -- | -- | -- |
| EBITDA | -- | -274.79% | -- | -- | -- |
| EPS Basic | -- | -93.06% | -- | -- | -- |
| Normalized Basic EPS | -- | -89.90% | -- | -- | -- |
| EPS Diluted | -- | -93.06% | -- | -- | -- |
| Normalized Diluted EPS | -- | -89.90% | -- | -- | -- |
| Average Basic Shares Outstanding | -- | 73.91% | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | 73.91% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |